Clinical trials / NCT05671835
NCT05671835Phase 2Completed

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

Study sponsor: Tvardi Therapeutics, Incorporated

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2025-08-14Actual
Enrollment · participants100Actual
Source updated2026-08-13Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

75 participants (planned)

+ After

100 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

25 Aug 2025

+ After

14 Aug 2025

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source